PBEvsFBTETF Comparison
VS
Invesco Dynamic Biotechnology & Genome ETF (PBE) belongs to the BioTech & Genomics segment. First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. PBE is more expensive with a Total Expense Ratio (TER) of 0.58%, versus 0.54% for FBT. PBE is up 2.54% year-to-date (YTD) with -$3M in YTD flows. FBT performs better with 10.4% YTD performance, and +$1.12B in YTD flows. Run a side-by-side ETF comparison of PBE and FBT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PBE vs FBT performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 06/12/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PBE FBT | +1.33%+8.63% | +10.39%+14.03% | +2.54%+10.40% | +31.31%+38.20% | +34.96%+44.56% | +10.44%+30.74% |
| Flows | PBE FBT | +$2M+$31M | -$3M+$23M | -$3M+$1.12B | -$26M+$1.16B | -$56M+$677M | -$45M+$382M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PBE FBT | +19.82%+24.91% | +19.09%+21.21% | +20.14%+20.51% | +22.41%+22.00% |
| Max drawdown | PBE FBT | -4.08%-4.56% | -11.70%-14.27% | -22.21%-19.92% | -34.74%-29.91% |
| Max drawdown duration | PBE FBT | 16d19d | 156d126d | 324d237d | 1540d1159d |
Trading data
PBE | FBT | |
Last sale 6/12/2026 at 1:30 PM | $84.10 | $225.61 |
| Previous close 06/11/2026 | $84.82 | $227.24 |
| Consolidated volume 06/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of May 29, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PBE | FBT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 6/12/2026 at 1:30 PM
Live
Closed
PBE | FBT | |
|---|---|---|
| Last price | $84.10 | $225.61 |
| 1D performance | -0.85% | -0.72% |
| AuM | $259.85 M | $2.63 B |
| E/R | 0.58% | 0.54% |
Characteristics
PBE | FBT | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | First Trust |
| Benchmark | Dynamic Biotech & Genome Intellidex Index | NYSE Arca Biotechnology Index |
| N° of holdings | 30 | 27 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 23, 2005 | June 19, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
PBE
USA
92.2%
Other
7.8%
FBT
USA
90.25%
Other
9.75%
Sectors
PBE
Health Care
97.78%
Other
2.22%
FBT
Health Care
87.26%
Other
12.74%
Advertisement
Diversification
PBE
Total weight of top 15 holdings out of 15
62.95%
FBT
Total weight of top 15 holdings out of 15
52.3%
Top 15 holdings
Data as of April 30, 2026
PBE
UTD THERAPEUT
6.20%
ILLUMINA
5.42%
REGENERON PHARMACEUTICALS
4.99%
INCYTE
4.91%
ALNYLAM PHARMACEUTICALS
4.80%
BIOGEN INC
4.80%
AMGEN-T
4.60%
GILEAD SCIENCES
4.48%
CATALYST PHARMACEUTICALS INC
3.42%
BIOCRYST PHARMACEUTICALS
3.30%
TG THERAPEUTICS
3.28%
ARROWHEAD PHARMACEUTICALS INC
3.27%
CAREDX INC/D
3.21%
PROTAGONIST THERAPEUTICS INC
3.18%
ROYALTY PHARMA
3.09%
FBT
NEOGENOMICS
3.86%
ADMA BIOLOGICS INC
3.69%
CORCEPT THERAPEUTICS
3.66%
ARROWHEAD PHARMACEUTICALS INC
3.54%
VERACYTE INC/D
3.54%
BIONTECH SE ADR
3.51%
BIOGEN INC
3.49%
ILLUMINA
3.45%
KRYSTAL BIOTECH INC
3.42%
AXSOME THERA CMN STK
3.42%
NATERA
3.41%
ALKERMES
3.36%
INCYTE
3.35%
EXELIXIS
3.34%
UTD THERAPEUT
3.27%
Frequently asked questions about PBE and FBT
How have the PBE and FBT ETFs performed in 2026?
As of June 12, 2026, PBE is up 2.54% year-to-date (YTD), while FBT has returned 10.4%. That puts FBT better performer ahead so far this year.
Which ETF is attracting more investor money: PBE or FBT?
Year-to-date, the PBE ETF saw -$3M in flows, compared to +$1.12B for FBT.
Which ETF is more volatile: PBE or FBT?
Over the past year, PBE had a volatility of 19.09%, while FBT experienced 21.21%.
Which ETF is bigger: PBE or FBT?
As of June 12, 2026, PBE holds $259.85 M in assets under management (AUM), while FBT manages $2.63 B.
What sectors do the PBE and FBT ETFs invest in?
PBE leans toward sectors like Health Care. Meanwhile, FBT focuses on Health Care.
What are the top holdings of the PBE ETF and FBT ETF?
PBE top holdings include UTD THERAPEUT, ILLUMINA and REGENERON PHARMACEUTICALS. FBT holds in its top three: NEOGENOMICS, ADMA BIOLOGICS INC and CORCEPT THERAPEUTICS.
Which ETF is more diversified: PBE or FBT?
PBE holds 30 securities with 62.95% of its assets in the top 15. FBT has 28 securities and a top 15 weight of 52.3%.
Advertisement
Latest news about PBE & FBT
Advertisement
